Keith A. Goldan
CIK 1495411 · Chief Financial Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.67M
Companies
5
Total Filings
40
Lifetime Open-Market Net
-$196.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNDX | Chief Financial Officer | 139,252 | $20.37 | $2.84M | -$195.4K | 14 | 2026-06-02 |
| ABEO | Director | 32,751 | $7.45 | $244.0K | $0 | 1 | 2026-04-07 |
| OptiNose, Inc. (OPTN) Delisted | Chief Financial Officer | 9,448 | $9.60 | $90.7K | -$13.7K | 13 | 2022-03-17 |
| Fibrocell Science, Inc. (FCSC) Delisted | SVP and CFO | 133 | — | — | $12.7K | 2 | 2016-03-02 |
| PATH | CFO and VP | 166,066 | $15.59 | $2.59M | $0 | 4 | 2013-01-22 |
Recent Filings · Page 4 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-09 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | +941 | $5.3K | EDGAR |
| 2019-03-06 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-16 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-02 | Fibrocell Science, Inc. (FCSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-11 | Fibrocell Science, Inc. (FCSC) Delisted | Buy (P) | +2,000 | $12.7K | EDGAR |
| 2014-02-25 | — | Mixed | −166,066 | -$1.13M | |
| 2013-01-22 | PATH | Grant (A) | +125,000 | $0 | EDGAR |
| 2013-01-09 | PATH | Mixed | +36,274 | $0 | EDGAR |
| 2012-03-27 | PATH | Grant (A) | — | $0 | EDGAR |
| 2010-08-12 | PATH | Conv (C) | +4,792 | $7.7K | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.